Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,515 | 188 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $548.28 | 30 | $0 (2024) |
| Novo Nordisk Inc | $440.27 | 25 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $303.23 | 20 | $0 (2023) |
| Boston Scientific Corporation | $241.58 | 2 | $0 (2022) |
| Amgen Inc. | $223.35 | 12 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $175.75 | 9 | $0 (2021) |
| GlaxoSmithKline, LLC. | $164.90 | 12 | $0 (2023) |
| PFIZER INC. | $162.62 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $137.40 | 7 | $0 (2023) |
| Horizon Therapeutics plc | $123.19 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.12 | 4 | ABBVIE INC. ($78.12) |
| 2023 | $431.28 | 24 | ABBVIE INC. ($106.21) |
| 2022 | $1,194 | 66 | Novo Nordisk Inc ($184.74) |
| 2021 | $1,811 | 94 | AbbVie Inc. ($313.33) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 8 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Neuroscience | ||||||
| 03/02/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: OBESITY | ||||||
| 03/01/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PRIMARY CARE | ||||||
| 02/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: VACCINES | ||||||
| 02/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: PRIMARY CARE | ||||||
| 02/09/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2021 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PRIMARY CARE | ||||||
| 01/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 375 | 1,708 | $627,962 | $104,076 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 61 | 704 | $213,312 | $36,263 | 17.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 34 | 326 | $98,778 | $16,792 | 17.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 50 | 212 | $84,376 | $15,544 | 18.4% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 62 | 133 | $78,576 | $11,699 | 14.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 32 | 138 | $54,924 | $10,118 | 18.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 56 | 109 | $41,568 | $5,567 | 13.4% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 16 | 20 | $16,356 | $2,575 | 15.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 17 | 17 | $7,794 | $1,545 | 19.8% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 15 | 15 | $12,395 | $1,489 | 12.0% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2023 | 15 | 16 | $7,336 | $1,454 | 19.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 18 | $12,546 | $1,029 | 8.2% |
About Genesis Flanagan, APRN
Genesis Flanagan, APRN is a Family healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1396107223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Genesis Flanagan, APRN has received a total of $3,515 in payments from pharmaceutical and medical device companies, with $78.12 received in 2024. These payments were reported across 188 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,515).
As a Medicare-enrolled provider, Flanagan has provided services to 375 Medicare beneficiaries, totaling 1,708 services with total Medicare billing of $104,076. Data is available for 1 year (2023–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Naples, FL
- Active Since 03/21/2016
- Last Updated 08/12/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1396107223
Products in Payments
- FARXIGA (Drug) $225.43
- Ozempic (Drug) $215.26
- NURTEC ODT (Drug) $213.20
- UBRELVY (Drug) $197.03
- VRAYLAR (Drug) $164.14
- Aimovig (Biological) $152.63
- TRELEGY ELLIPTA (Drug) $151.68
- ENTRESTO (Drug) $137.40
- General - Structural Heart (Device) $124.88
- KRYSTEXXA (Biological) $123.19
- VENOUS WALLSTENT (Device) $116.70
- Saxenda (Drug) $104.81
- BOTOX (Biological) $98.75
- QULIPTA (Drug) $93.98
- SUNOSI (Drug) $89.47
- PREVNAR 20 (Biological) $88.90
- TRINTELLIX (Drug) $86.79
- Otezla (Drug) $70.72
- Vascepa (Drug) $68.82
- SPRAVATO (Drug) $68.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Naples
Lauren Bond
Family — Payments: $15,665
Diana Perez-Charton, Aprn, Msn, Rn, APRN, MSN, RN
Family — Payments: $14,035
Mrs. Joy Millet, Aprn, APRN
Family — Payments: $11,254
Mrs. Erin Conniff, Aprn, APRN
Family — Payments: $10,172
Kearston Perfetto, Arnp, ARNP
Family — Payments: $9,246
Jill Bittinger, Msn Fnp, MSN FNP
Family — Payments: $7,757